GTBP
GTBP
NASDAQ · Biotechnology

Gt Biopharma Inc

$0.41
-0.01 (-1.50%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +5,989.2% upside
Low Target $15.48
Average Target $24.85
High Target $31.61
Current Price $0.41
Current
$0.41
Target
$24.85
$15.48 $24.85 avg $31.61
Scenario Analysis
Bear Case
$15.48
3,693.2%
Low target
Base Case
$24.85
+5,989.2%
Avg target
Bull Case
$31.61
+7,645.7%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$3.85
-89.4% from high
52-Week Low
$0.39
+4.2% from low
Target vs 52W High
$24.85
+545.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +18.4%
AMGN
Amgen Inc
Hold 42 50% $190.87 -45.8%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +160.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -1.8%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.1%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -28.5%